Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Therapy
Data on breast cancer therapy discussed by researchers at Erasmus University
July 31st, 2008
Research findings, 'Signaling by estrogens and tamoxifen in the human endometrium,' are discussed in a new report. According to recent research published in the Journal of Steroid Biochemistry and Molecular Biology, "Tamoxifen is used as adjuvant treatment for postmenopausal breast cancer patients. The mechanism of action of tamoxifen in breast cancer patients is that tamoxifen inhibits growth of cancer cells by competitive antagonism for estrogens at the estrogen receptor (ER)." "In the endometrium, tamoxifen has an effect that varies with the ambient concentration of estrogen: in premenopausal women (high estrogen levels), tamoxifen displays an...
Source: Women's Health Weekly (2008-07-31)
|
